Radiographic damage in early rheumatoid arthritis is associated with increased disability but not with pain—a 5-year follow-up study

Autor: Anna Eberhard, Emil Rydell, Kristina Forslind, Stefan Bergman, Thomas Mandl, Tor Olofsson, Lennart T. H. Jacobsson, Carl Turesson

Publikováno v: Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-10 (2023)

Abstract Objectives To evaluate how radiographic damage, overall and measured as joint space narrowing score (JSNS) and erosion score (ES), as well as other clinical and laboratory measures, relate to disability and pain in early rheumatoid arthritis

Externí odkaz: https://doaj.org/article/78d17a74fb904cab99b2a73d777e1e41

Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis

Autor: Jonas Sagard, Tor Olofsson, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Johan K. Wallman

Publikováno v: Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-14 (2022)

Abstract Background Based on clinical and genetic associations, axial spondyloarthritis (axSpA) and inflammatory bowel disease (IBD) are suspected to have a linked pathogenesis. Gut dysbiosis, intrinsic to IBD, has also been observed in axSpA. It is,

Externí odkaz: https://doaj.org/article/6af765f9144b4ab29b51e99f3646e856

Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients

Autor: Per Nived, Göran Jönsson, Bo Settergren, Jon Einarsson, Tor Olofsson, Charlotte Sværke Jørgensen, Lillemor Skattum, Meliha C. Kapetanovic

Publikováno v: Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-12 (2020)

Abstract Objective To explore whether a prime-boost vaccination strategy, i.e., a dose of pneumococcal conjugate vaccine (PCV) and a dose of 23-valent polysaccharide vaccine (PPV23), enhances antibody response compared to single PCV dose in patients

Externí odkaz: https://doaj.org/article/1bd391697d0546af996b05890bc79f56

Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients

Autor: Per Nived, Göran Jönsson, Bo Settergren, Jon Einarsson, Tor Olofsson, Charlotte Sværke Jørgensen, Lillemor Skattum, Meliha C. Kapetanovic

Publikováno v: Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-2 (2020)

An amendment to this paper has been published and can be accessed via the original article.

Externí odkaz: https://doaj.org/article/d086f18bf21c42a0b30c8b924e119aae

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis:data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

Autor: Pedro M Machado, Martin Schäfer, Satveer K Mahil, Jean Liew, Laure Gossec, Nick Dand, Alexander Pfeil, Anja Strangfeld, Anne Constanze Regierer, Bruno Fautrel, Carla Gimena Alonso, Carla G S Saad, Christopher E M Griffiths, Claudia Lomater, Corinne Miceli-Richard, Daniel Wendling, Deshire Alpizar Rodriguez, Dieter Wiek, Elsa F Mateus, Emily Sirotich, Enrique R Soriano, Francinne Machado Ribeiro, Felipe Omura, Frederico Rajão Martins, Helena Santos, Jonathan Dau, Jonathan N Barker, Jonathan Hausmann, Kimme L Hyrich, Lianne Gensler, Ligia Silva, Lindsay Jacobsohn, Loreto Carmona, Marcelo M Pinheiro, Marcos David Zelaya, María de los Ángeles Severina, Mark Yates, Maureen Dubreuil, Monique Gore-Massy, Nicoletta Romeo, Nigil Haroon, Paul Sufka, Rebecca Grainger, Rebecca Hasseli, Saskia Lawson-Tovey, Suleman Bhana, Thao Pham, Tor Olofsson, Wilson Bautista-Molano, Zachary S Wallace, Zenas Z N Yiu, Jinoos Yazdany, Philip C Robinson, Catherine H Smith

Publikováno v: Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect), Machado, P M, Schäfer, M, Mahil, S K, Liew, J, Gossec, L, Dand, N, Pfeil, A, Strangfeld, A, Regierer, A C, Fautrel, B, Alonso, C G, Saad, C G S, Griffiths, C E M, Lomater, C, Miceli-Richard, C, Wendling, D, Alpizar Rodriguez, D, Wiek, D, Mateus, E F, Sirotich, E, Soriano, E R, Ribeiro, F M, Omura, F, Rajão Martins, F, Santos, H, Dau, J, Barker, J N, Hausmann, J, Hyrich, K L, Gensler, L, Silva, L, Jacobsohn, L, Carmona, L, Pinheiro, M M, Zelaya, M D, Severina, M D L Á, Yates, M, Dubreuil, M, Gore-Massy, M, Romeo, N, Haroon, N, Sufka, P, Grainger, R, Hasseli, R, Lawson-Tovey, S, Bhana, S, Pham, T, Olofsson, T, Bautista-Molano, W & Yiu, Z Z N 2023, ' Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis : data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries ', Annals of the rheumatic diseases . https://doi.org/10.1136/ard-2022-223499
Annals of the rheumatic diseases, vol 82, iss 5

ObjectivesTo investigate factors associated with severe COVID-19 in people with psoriasis (PsO), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).MethodsDemographic data, clinical characteristics and COVID-19 outcome severity of adults w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d66096c41f1b9d541954016b7ba44b
https://doi.org/10.1136/ard-2022-223499